Abstract
Ribosome engineering has been widely utilized for strain improvement, especially for the activation of bacterial secondary metabolism. This study assessed ribosome engineering technology to modulate primary metabolism, taking vitamin B12 production as a representative example. The introduction into Propionibacterium shermanii of mutations conferring resistance to rifampicin, gentamicin, and erythromycin, respectively, increased per cell production (μg/L/OD600) of vitamin B12 5.2-fold, although net production (μg/L) was unchanged, as the cell mass of the mutants was reduced. Real-time qPCR analysis demonstrated that the genes involved in vitamin B12 fermentation by P. shermanii were activated at the transcriptional level in the drug-resistant mutants, providing a mechanism for the higher yields of vitamin B12 by the mutants. These results demonstrate the efficacy of ribosome engineering for the production of not only secondary metabolites but of industrially important primary metabolites.
References
Feb 24, 2001·Cellular and Molecular Life Sciences : CMLS·E RauxM J Warren
Apr 6, 2002·Applied Microbiology and Biotechnology·J H MartensD Jahn
Aug 28, 2002·Natural Product Reports·Martin J WarrenJorge C Escalante-Semerena
Oct 20, 2005·Journal of Bioscience and Bioengineering·Yongzhe PiaoYoshikatsu Murooka
Dec 3, 2008·Journal of Bacteriology·Adelfia TalàPietro Alifano
Apr 28, 2009·Nature Biotechnology·Takeshi HosakaKozo Ochi
May 27, 2009·International Journal of Food Microbiology·Catherine M BurgessDouwe van Sinderen
Jun 17, 2010·The Journal of Antibiotics·Yukinori TanakaKozo Ochi
Jun 18, 2010·Journal of Biotechnology·Ying ZhangZong-Wan Mao
Jul 30, 2010·PloS One·Hélène FalentinSylvie Lortal
May 31, 2011·International Journal of Food Microbiology·Anne ThierryGwenaël Jan
Apr 12, 2012·The Journal of Antibiotics·Yu ImaiTakeshi Hosaka
Apr 28, 2012·Biotechnology Advances·Zhen KangJian Chen
May 9, 2012·Current Microbiology·Xiaofeng GaoYanling Jin
Jun 8, 2012·International Journal of Evolutionary Biology·Yuh ShiwaHirofumi Yoshikawa
Nov 13, 2012·Applied Microbiology and Biotechnology·Kozo Ochi, Takeshi Hosaka
Apr 23, 2013·Journal of Bacteriology·Yukinori TanakaKozo Ochi
Oct 16, 2013·Journal of Industrial Microbiology & Biotechnology·Kozo OchiShigeo Tojo
Mar 25, 2014·New Biotechnology·Simon J MooreMartin J Warren
Oct 11, 2014·Biotechnology Journal·Yin Li
Dec 3, 2014·Bioresource Technology·Toshihiro SuzukiToshiaki Nakajima-Kambe
Dec 8, 2014·Journal of Biotechnology·Pietro AlifanoAdelfia Talà
Jul 7, 2016·The Journal of Antibiotics·Kozo Ochi
Citations
May 10, 2019·Biotechnology Journal·Lorena Fernández-CabezónPablo I Nikel
Sep 5, 2019·Antibiotics·Saibin ZhuYong Huang
Feb 28, 2020·Molecular Biotechnology·Tianwen WangLei Nie
Dec 28, 2017·Applied Microbiology and Biotechnology·Xiangcheng ZhuYanwen Duan
Aug 9, 2020·Microbial Cell Factories·Yunchang XieQi Chen
May 1, 2021·International Journal of Molecular Sciences·Larissa BalabanovaLiudmila Tekutyeva
Nov 21, 2017·Chemical Reviews·László T MikaÁron Németh
Sep 3, 2021·Biotechnology Journal·Zilong WangYong Huang